【摘要】 目的探讨机器人超凝缝合法与传统达芬奇手术方式在Kimura保脾胰体尾切除术中的临床疗效及安全性。方法回顾性分析2014年10月至2020年1月在青岛大学附属医院因胰腺体尾部良性肿瘤行达芬奇辅助下Kimura胰体尾切除术的31例患者。采用机器人超凝缝合法的患者8例(试验组)和采用传统手的患者23例(对照组),比较两组患者的手术时间、术中出血量、术后引流管引流量、术后引流液淀粉酶、手术费用、拔除引流管时间、术后住院时间、术后病理等。结果试验组8例患者,其中男1例、女7例;年龄23～62岁,平均43岁;对照组23例患者,其中男5例、女18例,年龄19～75岁,平均49岁。试验组与对照组单因素分析:性别(P=0.584),年龄(P=0.445),术后并发症(P=0.036),手术时间(P=0.992),术中出血量(P=0.909),术后住院时间(P=0.403),手术费用(P=0.527)。结论机器人超凝缝合法在达芬奇辅助下Kiruma保脾胰体尾切除术中安全、有效,值得临床推广。更多还原

【Abstract】 To investigate the clinical efficacy and satety of robotic ultrasonic-coagulation-suture in spleen-preserving distal pancreatectomy with the Kimura the technique.Method The study retrospectively analyzed 31 patients undergoing robotic pancreaticoduodenectomy and distal pancreatectomy from Oct,2014 to Jan.2020 in the affiliated of hospital of Qingdao University.The operation time,bleeding during placement,postoperative drainage volume,postoperative drainage fluid amylase,surgical expenses,drainage tube removal time,postoperative hospitalization days and the pathology were compared between the observation group and the control group.Results There were 8 patients in the observation group,including1 males and 7 females,age 23-62 years old,average age 43 years old;In the control group,there were 23 patients,including 5 males and 18 females,aged 19-75 years with an average age of 49 years.The singlefactor analysis of the experimental group and control group showed:gender(P=0.584),age(P=0.445),postoperative complications(P=0.036),operation time(P=0.992),intraoperative bleeding(P=0.909),postoperative hospitalization(P=0.403),surgery expense(P=0.527).Conclusions Robotic ultrasonic-coagulation-suture is safe,reliable,simple.It is worthy of widespread promotion.更多还原